Product Images Fenofibrate

Each tablet contains 48 mg fenofibrate, USP. This medication is used to reduce cholesterol and triglycerides in the blood. It should be stored at 20-25°C (68-77°F) in a moisture-free place, and out of children's reach. This package is child-resistant. The medication should be dispensed in a USP tight container and should not be used if the seal is broken or missing. For more information on dosage and usage, see the package insert. The manufacturer is Gravit Pharmaceuticals, based in Wilmington, Delaware, USA, and the medication is manufactured in Telangana, India. NDC 69844-012-01 is the national drug code for Fenofibrate Tablets, USP. The expiration date is not readable in the provided text.*

This is a description of Fenofibrate Tablets, USP. Each tablet contains 145 mg fenofibrate and the package insert should be consulted for full prescribing information. The tablets should be stored at 20° to 25°C (68° to 77°F) in a moisture-free environment. The package is child-resistant and should be kept out of children's reach. Fenofibrate Tablets, USP should be dispensed in a USP tight container, and the bottle should not be accepted if the seal is broken or missing. The tablets are manufactured for Graviti Pharmaceuticals Inc. in the USA and manufactured by Gravit Pharmaceuticals Pyt. Ltd. in Telangana, INDIA. The NDC code for this product is 69844-013-01, and this is a Rx only medicine. The description includes a batch and expiration date which is not available.*